Nordic Liposomes ApS: Financial statements 2025
CVR: 43161725
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
Nordic Liposomes ApS (CVR 43161725) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 546,069 and a net result of DKK 336,862 compared with DKK 66,871 the year before. That is an increase of 445% compared with the year before. Equity in the 2025 report amounted to DKK 443,608. The solvency ratio was 49.4%.
- Gross Profit
- DKK 546,069
- Profit/Loss
- DKK 336,862
- Equity
- DKK 443,608
- Total Assets
- DKK 898,003
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | 546K | 337K | 444K | 0 |
| 2024 | - | 100K | 67K | 107K | 0 |
| 2023 | - | 104K | 68K | 40K | 0 |
Official annual report
How creditworthy is Nordic Liposomes ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
Nordic Liposomes ApS has published its annual report for 2024. Gross profit came to DKK 100,194, and the net result was DKK 66,871.
About Nordic Liposomes ApS
Nordic Liposomes ApS is a Danish company of the type Anpartsselskab based in Søndersø, founded in 2022. The company is registered under the industry Andre fremstillingsaktiviteter i.a.n.. The company was previously named Nordicliposomes ApS. The management consists of Morten Thvilum and Trine Albers Huusfeldt. The company is owned by CIRRUS HOLDING ApS and Huusfeldt ApS. The company has 1 employee (2026). In 2025, the company reported a gross profit of DKK 546,069 and a net result of DKK 336,862 compared with DKK 66,871 the year before. Equity in the 2025 report amounted to DKK 443,608.
